Dominique B Buck1, Eleonora G Karthaus2, Peter A Soden2, Klaas H J Ultee2, Joost A van Herwaarden3, Frans L Moll3, Marc L Schermerhorn4. 1. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. 3. Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. Electronic address: mscherme@bidmc.harvard.edu.
Abstract
OBJECTIVE: Prior studies suggest that percutaneous access for endovascular abdominal aortic aneurysm repair (pEVAR) offers significant operative and postoperative benefits compared with femoral cutdown (cEVAR). National data on this topic, however, are limited. We compared patient selection and outcomes for elective pEVAR and cEVAR. METHODS: We identified all patients undergoing either pEVAR (bilateral percutaneous access, whether successful or not) or cEVAR (at least one planned groin cutdown) for abdominal aortic aneurysms from January 2011 to December 2013 in the Targeted Vascular data set from the American College of Surgeons National Surgical Quality Improvement Program database. Emergent cases, ruptures, cases with an iliac conduit, and cases with a preoperative wound infection were excluded. Groups were compared by χ(2) test or t-test or the Mann-Whitney test where appropriate. RESULTS: We identified 4112 patients undergoing elective EVAR, 3004 cEVAR patients (73%) and 1108 pEVAR patients (27%). Of all EVAR patients, 26% had bilateral percutaneous access; 1.0% had attempted percutaneous access converted to cutdown (4% of pEVARs); and the remainder had a planned cutdown, 63.9% bilateral and 9.1% unilateral. There were no significant differences in age, gender, aneurysm diameter, or prior open abdominal surgery. Patients undergoing cEVAR were less likely to have congestive heart failure (1.5% vs 2.4%; P = .04) but more likely to undergo any concomitant procedure during surgery (32% vs 26%; P < .01) than patients undergoing pEVAR. Postoperatively, pEVAR patients had shorter operative time (mean, 135 vs 152 minutes; P < .01), shorter length of stay (median, 1 day vs 2 days; P < .01), and fewer wound complications (2.1% vs 1.0%; P = .02). On multivariable analysis, the only predictor of percutaneous access failure was performance of any concomitant procedure (odds ratio, 2.0; 95% confidence interval, 1.0-4.0; P = .04). CONCLUSIONS: Currently, one in four patients treated at Targeted Vascular National Surgical Quality Improvement Program centers are getting pEVAR, which is associated with a high success rate, shorter operation time, shorter length of stay, and fewer wound complications compared with cEVAR.
OBJECTIVE: Prior studies suggest that percutaneous access for endovascular abdominal aortic aneurysm repair (pEVAR) offers significant operative and postoperative benefits compared with femoral cutdown (cEVAR). National data on this topic, however, are limited. We compared patient selection and outcomes for elective pEVAR and cEVAR. METHODS: We identified all patients undergoing either pEVAR (bilateral percutaneous access, whether successful or not) or cEVAR (at least one planned groin cutdown) for abdominal aortic aneurysms from January 2011 to December 2013 in the Targeted Vascular data set from the American College of Surgeons National Surgical Quality Improvement Program database. Emergent cases, ruptures, cases with an iliac conduit, and cases with a preoperative wound infection were excluded. Groups were compared by χ(2) test or t-test or the Mann-Whitney test where appropriate. RESULTS: We identified 4112 patients undergoing elective EVAR, 3004 cEVARpatients (73%) and 1108 pEVARpatients (27%). Of all EVAR patients, 26% had bilateral percutaneous access; 1.0% had attempted percutaneous access converted to cutdown (4% of pEVARs); and the remainder had a planned cutdown, 63.9% bilateral and 9.1% unilateral. There were no significant differences in age, gender, aneurysm diameter, or prior open abdominal surgery. Patients undergoing cEVAR were less likely to have congestive heart failure (1.5% vs 2.4%; P = .04) but more likely to undergo any concomitant procedure during surgery (32% vs 26%; P < .01) than patients undergoing pEVAR. Postoperatively, pEVARpatients had shorter operative time (mean, 135 vs 152 minutes; P < .01), shorter length of stay (median, 1 day vs 2 days; P < .01), and fewer wound complications (2.1% vs 1.0%; P = .02). On multivariable analysis, the only predictor of percutaneous access failure was performance of any concomitant procedure (odds ratio, 2.0; 95% confidence interval, 1.0-4.0; P = .04). CONCLUSIONS: Currently, one in four patients treated at Targeted Vascular National Surgical Quality Improvement Program centers are getting pEVAR, which is associated with a high success rate, shorter operation time, shorter length of stay, and fewer wound complications compared with cEVAR.
Authors: E Jean-Baptiste; R Hassen-Khodja; P Haudebourg; P-J Bouillanne; S Declemy; M Batt Journal: Eur J Vasc Endovasc Surg Date: 2007-12-31 Impact factor: 7.069
Authors: Rodney P Bensley; Rob Hurks; Zhen Huang; Frank Pomposelli; Allen Hamdan; Mark Wyers; Elliot Chaikof; Marc L Schermerhorn Journal: J Vasc Surg Date: 2012-02-22 Impact factor: 4.268
Authors: Markus Eisenack; Thomas Umscheid; Joerg Tessarek; Giovanni F Torsello; Giovanni B Torsello Journal: J Endovasc Ther Date: 2009-12 Impact factor: 3.487
Authors: Gezzer Ortega; Daniel S Rhee; Dominic J Papandria; Jessica Yang; Andrew M Ibrahim; Andrew D Shore; Martin A Makary; Fizan Abdullah Journal: J Surg Res Date: 2011-06-24 Impact factor: 2.192
Authors: Zachary M Arthurs; Benjamin W Starnes; Vance Y Sohn; Niten Singh; Charles A Andersen Journal: Ann Vasc Surg Date: 2008-07-26 Impact factor: 1.466
Authors: Patric Liang; Thomas F X O'Donnell; Nicholas J Swerdlow; Chun Li; Andy Lee; Mark C Wyers; Allen D Hamdan; Marc L Schermerhorn Journal: J Vasc Surg Date: 2019-03-07 Impact factor: 4.268
Authors: Suzanne M Vrancken; Boudewijn L S Borger van der Burg; Paul J E M Vrancken; Gert-Aldert H Kock; Todd E Rasmussen; Rigo Hoencamp Journal: Eur J Trauma Emerg Surg Date: 2020-05-29 Impact factor: 3.693